Back to Trials
NCT06446479PHASE2RecruitingAccepts Healthy Volunteers

Effects of THC on Alcohol Consumption and Neural Correlates of Reward

University of Colorado, Denver

Start Date

7/1/2024

Completion Date

6/30/2026

Summary

Alcohol and cannabis are often used together such that their effects overlap, but little is known about the neural mechanisms that underlie simultaneous use. High doses of THC have not been well-studied in the laboratory, and it is unclear how high doses of THC may impact alcohol consumption patterns. The proposed study will explore the effects of oral THC (20mg dronabinol) vs. placebo on neural reward, alcohol self-administration and naturalistic co-use patterns.

Detailed Description

Participants will undergo a screening assessment, baseline session and two laboratory visits. The laboratory visits will involve an MRI scan and the opportunity to consume alcohol in our BAR lab. Prior to the MRI, participants will consume, a placebo (0mg) or high (20mg) dose of oral THC (dronabinol). Visits will be separated by 7 to 14 days. Dronabinol is an FDA-approved product that will be dispensed by our on-campus pharmacy

Eligibility Criteria

Age Range: 21 years to 40 years

Inclusion Criteria: * Drink alcohol * Use cannabis * Contact site for additional details Exclusion Criteria: * MRI contraindications (implanted metal, weight \> 315 lb, etc.). * Contact site for additional details

Interventions

DRUG

Dronabinol Pill

DRUG

Placebo

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Cannabis Use Disorder

Locations

University of Colorado Anschutz Medical Campus

Aurora, Colorado 80045

United States